Please ensure Javascript is enabled for purposes of website accessibility
Search
Accessibility Menu

Top ETFs Tracking CRISPR Gene Editing

These exchange-traded funds track companies in this biotech space.

By Keith Speights – Updated Jun 18, 2025 at 1:26PM | Fact-checked by Frank Bass

Key Points

  • Several ETFs focus on CRISPR gene editing, including ARKG and GNOM.
  • ARKG owns shares in companies developing CRISPR therapies such as CRISPR Therapeutics.
  • WDNA tracks companies transformed by genetics and biotechnology, holding CRISPR stocks.
Key findings are powered by ChatGPT and based solely off the content from this article. Findings are reviewed by our editorial team. The author and editors take ultimate responsibility for the content.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.